India Cephalexin Market to grow at impressive rate During the Forecast Period
Growing prevalence of
bacterial infections is expected to drive the growth of India cephalexin
market.
According to
TechSci Research report, “India Cephalexin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Liquid
suspension, Injection, Others), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application
(Respiratory Tract Infections, Otitis Media, Skin and Skin Structure
Infections, Bone Infections, Genitourinary Infections, Others), By End User
(Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, the India cephalexin market is expected to grow
at a steady rate during the forecast period on account of the extensive use of
the drug in treating infections in inner ear, bones, joints, skin, among
others. Additionally, the antibiotic is effective in the treatment of strep
throat, pneumonia, bacterial endocarditis, among others. This in turn is
expected to positively influence the market growth until FY 2026. However, side
effects such as diarrhea, stomach pain, jaundice, dizziness, among others
associated with the consumption of cephalexin can restrict the market growth
over the next few years. Also, severe allergic reactions can be observed in
certain patients due to intake of cephalexin thereby slowing down the market
growth through FY2026.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on " India Cephalexin Market"
https://www.techsciresearch.com/report/india-cephalexin-market/5157.html
The India
cephalexin market is segmented based on source, form, route of administration, distribution
channel, application, end user, company and region. Based on source, the market
can be split in in-house and contract manufacturing organizations. The contract
manufacturing organizations segment is expected to witness significant growth
during the forecast period on account of the increasing outsourcing being done
by the major pharmaceutical companies for the manufacturing of APIs and drugs
so that they can focus on their R&D activities and expansion plans.
Additionally, these organizations have the capability to produce and provide
bulk quantities of formulation to their clients at affordable prices and in
lesser time. Based on form, the market can be categorized into tablet, capsule,
liquid suspension, injection and others. The tablet segment is expected to
dominate the market since it can accommodate a large amount of API as compared
to the other counterparts. While capsule segment is expected to register the
highest growth during the forecast period on account of the associated benefits
such as fast action, tamper resistance, higher rate of absorption, among
others. Based on distribution channel, the market can be split into online and
offline. The offline channel is expected to dominate the market owing to the
consumer preference for buying medicines from a pharmacy or drug store. The
online segment is also expected to register significant growth over the next
few years. This can be ascribed to the emergence of several online pharmacies
and doorstep drug delivery e-commerce platforms in the country.
Medico
Remedies Ltd., Dabur Pharma Ltd., Ajanta Pharma Ltd., Aristo Pharmaceuticals
Pvt. Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Cadila
Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Centurion
Laboratories Private Ltd., Alkem Laboratories Ltd. and others are some of the
leading players operating in India cephalexin market. Companies operating in
the market are using Go-to-Market strategies such as product launches, mergers
and acquisitions and research collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5157
Customers can
also request for 10% free customization on this report.
“India cephalexin market is
expected to witness growth during the forecast period on account of the growing
incidences of infections and disease caused due to a range of gram positive and
gram negative bacteria’s. Additionally, the antibiotic is present in the WHO’s
list of essential medicine thereby fueling the market growth through FY2026. Furthermore,
supportive government policies and schemes launched by the government of India
such as incentive linked production scheme, establishment of bulk drug parks,
among others.” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based India management consulting firm.
“India Cephalexin Market By Source (In-house
v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Liquid
suspension, Injection, Others), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application
(Respiratory Tract Infections, Otitis Media, Skin and Skin Structure
Infections, Bone Infections, Genitourinary Infections, Others), By End User
(Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, has evaluated
the future growth potential of India cephalexin market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in India cephalexin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]